Patient Factsheet teaser

What is in vitro maturation (IVM)?

Download a PDF of this document

Created 2014/Revised 2023


What is IVM?

In vitro maturation (IVM) is when eggs are collected and matured outside the body. This is done as part of an in vitro fertilization (IVF) procedure. Eggs (also called oocytes) are formed inside a developing fetus’ ovaries before birth. These eggs stay in a resting state in the ovaries until puberty, when normal hormonal changes cause an egg to mature (develop) and be released each month. During IVF, medications called “gonadotropins” result in more than one egg maturing at the same time. These eggs are then collected before they are released from the ovary and are then placed with sperm in the laboratory in hopes of fertilization. In some cases, some or all of the oocytes (eggs) that are collected are not mature and ready to be fertilized. In years past, these eggs were not able to be used for IVF. Advances in science are beginning to allow embryologists to take these immature eggs and sometimes “ripen” them in vitro (in the laboratory). This is called IVM.

The eggs may be frozen for later use (as immature eggs, mature eggs, or embryos after they have been combined with sperm and fertilized). Or, they may be matured, fertilized, and placed into the uterus in hopes of pregnancy.

Are women undergoing IVM required to take injectable medicines to induce ovulation?

In the strictest type of IVM, no medications are given to stimulate additional eggs to grow; immature eggs are taken from unstimulated ovaries. However, in a modified IVM cycle, low-dose injectable medications may be given.

What is the purpose of using medicine to stimulate the ovary for IVM?

In recent clinical studies, low-dose ovarian stimulation for removal of immature eggs may yield more eggs and improve the lining of the uterus to receive the embryo.

Why use IVM?

To prevent ovarian hyperstimulation syndrome (OHSS) IVM may be considered for women with polycystic ovary syndrome (PCOS) or PCO- like ovaries. These women are at greatest risk of OHSS. OHSS is an exaggerated response to medicines used to induce ovulation, especially after the use of injectable gonadotropin agents when hCG is used for final follicular maturation (for more information about OHSS, see the ASRM patient fact sheet titled Ovarian hyperstimulation syndrome [OHSS]). However, using different medication for final follicular maturation called leuprolide (GnRH agonist) instead of hCG greatly reduces this risk and can be used as an alternative to IVM.

In cancer patients

IVM may also be appropriate when waiting for fully mature eggs is not possible before cancer treatment begins. Another proposed application is in patients with estrogensensitive cancers. IVM may avoid or minimize the additional estrogen production that is seen with conventional ovarian stimulation. However, antiestrogen medications are also available during more traditional stimulation for mature oocyte cryopreservation while may ultimately result in a higher chance of successful pregnancy in the future.

Are there any benefits to IVM?

IVM requires less medication than conventional IVF and lowers the immediate cost of treatment; however, the pregnancy rates are also lower, so it is unclear whether IVM is more cost-effective and it is not widely available. An IVM cycle also takes less time.

Is IVM available today?

At present, this treatment is still considered experimental and is not recommended as a replacement for conventional IVF or mature oocyte cryopreservation. However, in certain situations, particularly when conventional IVF is not possible, IVM is an alternative treatment.

It is becoming more available, although pregnancy rates are lower in most cases. There may be certain groups of women who have equal success rates.

Would IVM benefit all infertile women?

At the present time, it appears that women who ovulate normally are not as successful with IVM than with conventional IVF. Research in this area is ongoing. Talk to your doctor to find out if IVM may be right for you.

Fact Sheets/Booklets

View more fact sheets and booklets written by the ASRM Patient Education Committee.
Patient Factsheet teaser

Menopausal Transition (Perimenopause): What Is It?

The menopausal transition (perimenopause) is the period that links a woman’s reproductive (childbearing) years and menopause.
Patient Factsheet teaser

Osteoporosis

Osteoporosis and osteopenia are conditions of having low bone mass (density).
Patient Factsheet teaser

Hyperprolactinemia (High Prolactin Levels)

Prolactin is a hormone produced by your pituitary gland which sits at the bottom of the brain.
Patient Factsheet teaser

Stress and infertility

It is not clear how exactly stress impacts fertility.

Resources For You

The American Society for Reproductive Medicine (ASRM) is committed to providing patients with the highest quality information about reproductive care.

In Vitro Fertilization (IVF)

PR Bulletin Icon

ASRM Releases Congressional Scorecard

Discover ASRM's first Congressional scorecard, detailing positions of the 118th Congress on key reproductive legislation to guide ASRM members in elections.

View the Press Release
PR Bulletin Icon

Fertility Care Gets Important Win in California

ASRM celebrates California's SB 729, expanding IVF coverage for same-sex couples and singles, advancing equitable fertility care access.

View the Press Release
PR Bulletin Icon

Nation’s Leading Professional Group for Fertility Care Professionals Calls for Passage of Right to IVF Act

ASRM applauds Majority Leader Schumer’s decision to seek reconsideration of the Right to IVF Act.

View the Press Release
Podcast Icon

SART Fertility Experts - Vanquishing Multiples

Learn how a variety of factors such as geography, race, and the availability of comprehensive infertility mandates affect access to effective infertility treatment. Listen to the Episode
PR Bulletin Icon

Trump Calls for IVF Coverage, California Legislature Sends IVF Mandate Bill to Governor

The California General Assembly approved a bill mandating most private health insurance plans to provide coverage for In Vitro Fertilization (IVF). 

View the Press Release
Advocacy Icon

Advocacy in Action

Join the ASRM Advocacy in Action campaign by making a tax-deductible charitable gift Be part of Advocacy in Action

Find a Health Professional

Connect with reproductive medicine experts who will guide you through your unique journey. Our search tool allows personalized matches based on location, specialization, and expertise. Take control of your reproductive health with compassionate providers, innovative treatments, and unwavering support.
Search for an Expert
Healthcare professional eager to help a patient
Reproductive facts Privacy Policy
Cookies on the ReproductiveFacts.org Website.

We use cookies to give you the best digital experiences while visiting our websites. By accepting the use of cookies and using our website you consent to our cookies in accordance to our privacy policy.

Privacy Policy     Cookie Policy